Share
407 Posts.
lightbulb Created with Sketch. 55
clock Created with Sketch.
17/03/23
17:57
Share
Originally posted by sylau90:
↑
That might be true, the most obvious one was Mickey. He went quiet all of the sudden. That's why I only use hotcopper as a overall market sentiment for short term trading. Long term trading? yeah nah... I can't even figure out what I would be having for tomorrow dinner or how many cars I will overtake on my way home everyday, let along trusting someone with my money for 5 years in a speccies company. At the end of the day, if this company poses such great opportunity, Big Pharma would have had taken over by now. Pfizer has $26B USD free cashflow just FYI. They would obviously study the patents held by IHL and methods used. If the drugs of IHL poses 50% chance of success, I think Pfizer wouldn't mind snapping it up. They can afford to lose billion of dollars back in 2006 on torcetrapib, I don't they would mind buying 50% of IHl for $70mil.
Expand
As far as buyouts go, I'm quite certain that most drugs / therapies aren't looked at until they are almost entirely derisked. Let's revisit that question when our trials get to / complete Phase 3.